dasatinib sandoz 100 mg
sandoz pharmaceuticals d.d., slovinsko - dazatinib - 44 - cytostatica
dasatinib sandoz 70 mg
sandoz pharmaceuticals d.d., slovinsko - dazatinib - 44 - cytostatica
dasatinib sandoz 50 mg
sandoz pharmaceuticals d.d., slovinsko - dazatinib - 44 - cytostatica
dasatinib sandoz 20 mg
sandoz pharmaceuticals d.d., slovinsko - dazatinib - 44 - cytostatica
dasatinib zentiva 100 mg filmom obalené tablety
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
dasatinib zentiva 70 mg filmom obalené tablety
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
dasatinib zentiva 50 mg filmom obalené tablety
zentiva, k.s., Česká republika - dazatinib - 44 - cytostatica
dasatinib mylan 100 mg
mylan ireland limited, Írsko - dasatinib - 44 - cytostatica
dasatinib mylan 70 mg
mylan ireland limited, Írsko - dasatinib - 44 - cytostatica
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastické činidlá - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.